Harry Stannard Asia-Pacific Vaccine and Immunotherapy Congress 2024

Harry Stannard

Our team at the WHO CCRRI (VIDRL, Peter Doherty Institute, Melbourne) performs research on influenza virus antivirals. My work utilises the ferret influenza challenge model to study novel antiviral resistant viruses, and potential antiviral drugs/drug combinations, ultimately to research the most effective antiviral treatment methods of human influenza.

Abstracts this author is presenting: